By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

American Association for Cancer Research 

615 Chestnut St.
17th Floor
Philadelphia  Pennsylvania  19106-3483  U.S.A.
Phone: 215-440-9300 Fax: 215-440-9313


SEARCH JOBS








Company News
Puma Biotechnology (PBYI) Announces Positive Interim PB272 (Neratinib) Phase 2 Data At 2014 CTRC-American Association for Cancer Research San Antonio Breast Cancer Symposium 12/12/2014 8:12:35 AM
Oncolytics Biotech Inc. (ONC.TO) Collaborators Present REOLYSIN And Checkpoint Inhibitor Combination Preclinical Data At American Association for Cancer Research Tumor Immunology And Immunotherapy Conference 12/5/2014 12:54:35 PM
ZIOPHARM Oncology, Inc. (ZIOP.OB) And Intrexon Corporation Present Clinical And Preclinical Data From Immuno-Oncology Programs At Intrexon Corporation Tumor Immunology And Immunotherapy Meeting 12/4/2014 4:22:42 PM
Aduro Biotech Announces Preclinical Data Presented At American Association for Cancer Research Tumor Immunology And Immunotherapy Conference 12/4/2014 9:07:33 AM
OncoMed Pharmaceuticals, Inc. (OMED) Presents New Clinical And Biomarker Data From Its Tarextumab And Demcizumab Clinical Trials At The European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium 11/24/2014 12:55:50 PM
Merrimack Pharmaceuticals Inc. (MACK) Presents On Multiple Programs At The 26th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium On Molecular Targets And Cancer Therapeutics 11/21/2014 2:46:31 PM
3-V Biosciences Announces Presentation Of First Human Clinical Data For Lead Oral FASN Inhibitor Candidate At European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research 2014 11/19/2014 3:38:49 PM
OncoMed Pharmaceuticals, Inc. (OMED) Presents Biomarker-Focused Clinical Data From Phase 1a Trial Of Anti-Notch1 (OMP-52M51) In Oral Plenary Session At The 26th OncoMed Pharmaceuticals, Inc. (OMED)-European Organization for Research and Treatment of Cancer-National Cancer Institute Symposium 11/19/2014 9:35:09 AM
Debiopharm Group Presents Advances Of Two Key Oncology Clinical Programs At The 26th European Organization for Research and Treatment of Cancer-National Cancer Institute-American Association for Cancer Research Symposium In Barcelona 11/18/2014 1:12:12 PM
Epic Sciences To Present Data On A Combination CTC And cfDNA Assay For Molecular Targets Of Non-Small Cell Lung Cancer Therapies At The 26th EORTC-National Cancer Institute-American Association for Cancer Research Symposium 11/17/2014 11:57:43 AM
12345678910...
//-->